Table 1.

Some miRNAs with altered expression in malignancy

Tissue/tumor typeIncreased expressionDecreased expression
Lungmir-17-92cluster, miR-17-5plet-7 family
BreastmiR-21, miR-29b-2miR-125b, miR-145 miR-10b, miR-155, miR-17-5p, miR-27b
GlioblastomamiR-221, miR-21miR-181a, miR-181b, miR-181c
Chronic lymphocytic leukemiamiR-15, miR-16
LymphomamiR-155, miR-17-92clustermiR-15a
ColorectalmiR-10a, miR-17-92 cluster, miR-20a, miR-24-1, miR-29b-2, miR-31miR-143, miR-145, let-7
ThyroidmiR-221, miR-222, miR-146, miR-181b, miR-197, miR-346
HepatocellularmiR-18, miR-224miR-199a, miR-195, miR-200a, miR-125a
TesticularmiR-372, miR-373
PancreaticmiR-221, miR-376a, miR301, miR-21, miR-24-2, miR-100, miR-103-1,2, miR-107, miR-125b-1miR-375
CholangiocarcinomamiR-21, miR-141, miR-200b
Prostatelet-7d, miR-195, miR-203miR-128a
GastricmiR-223, miR-21, miR-103-2miR-218-2